Fidelity Ethereum Fund Fidelity Ethereum Fund (BATS: FETH)

Ultime notizie per Fidelity Ethereum Fund Fidelity Ethereum Fund (BATS:FETH)

The Trusts investment objective is to seek to track the performance of ether, as measured by the performance of the Fidelity Ethereum Reference Rate (the Index), adjusted for the Trusts expenses and other liabilities.

Fidelity Ethereum Fund

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

ETHV

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

Fidelity Ethereum Fund Fidelity Ethereum Fund

FETH

GBTC

Secondo un nuovo report di Standard Chartered, una potenziale vittoria di Donald Trump alle elezioni di novembre sarebbe più positiva per il Bitcoin.

Elezioni USA: Trump potrebbe far decollare il BTC a $125.000

Macro Economic Events

Econ #s

Economics

Core CPI (YoY) (Mar) +2.8% vs +3% Est.; +3.1% Prior

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) reported first-quarter revenue growth of 41.6% year-on-year to <a target="_blank" href="https://pr.tsmc.com/english/news/3219" rel="noreferrer noopener">839.25 billion New Taiwan dollars ($25.5 billion)</a> on Thursday.
In March, key contract chipmaker chief C.C. Wei announced an additional $100 billion&nbsp;investment&nbsp;in U.S. chipmaking (on top of $65 billion in April 2024)
The investment followed <a target="_blank" href="https://www.benzinga.com/25/04/44597633/taiwan-semiconductors-stock-slides-18-amid-concerns-over-us-expansion-and-intel-rivalry" rel="noreferrer noopener">President Trump&#8217;s verbal attacks</a> of Taiwan &#8220;stealing&#8221; the U.S. semiconductor business, leading to massive trade deficits for Washington.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44651259/asml-stock-hits-52-week-low-as-trumps-eu-tariffs-and-china-sanctions-weigh-on-outlook" rel="noreferrer noopener">Trump&#8217;s EU Tariffs Impacts Chip Equipment Giant ASML, Stock Hits 52-Week Low</a>
TSMC is embroiled in the U.S. geopolitical tensions. Trump has <a target="_blank" href="https://www.benzinga.com/25/04/44665533/taiwan-semiconductor-stock-tumbles-as-tariff-fears-spark-global-tech-selloff" rel="noreferrer noopener">slammed Taiwan</a> for the lack of a defense treaty, as the U.S. is a key military backer of Taiwan.
The President had suggested scrapping&nbsp;U.S. subsidies to chipmakers like Taiwan Semiconductor to build fabs in the country to boost its semiconductor position.
Despite the huge U.S. investment commitment, Taiwan Semiconductor&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/emerging-markets/25/03/44563420/despite-us-expansion-taiwan-semiconductor-reaffirms-commitment-to-home-base-with-new-initiatives-reuters" rel="noreferrer noopener">reiterated its commitment</a>&nbsp;to domestic investments and keeping advanced tech in Taiwan.
In 2023, Taiwan Semiconductor held 67% of the market share in contracted semiconductor manufacturing and ~80% in advanced technology products. Taiwan Semiconductor accounts for&nbsp;over a third&nbsp;of the Taiwan benchmark&#8217;s weight.
Taiwan Semiconductor stock has plunged over 21% year-to-date. Steven Tseng of Bloomberg Intelligence&nbsp;<a target="_blank" href="https://www.benzinga.com/government/regulations/25/04/44713681/taiwan-semi-could-face-more-than-1-billion-in-us-penalty-over-alleged-huawei-chip-link-reuters" rel="noreferrer noopener">expects the tariffs</a> to indirectly reduce orders for Taiwan Semiconductor-manufactured chips via lower consumer demand.&nbsp;
Goldman Sachs downgraded&nbsp;Taiwan equities to underweight, citing high exposure to U.S. exports.
Price Action:&nbsp;TSM stock is down 1.33% to $156.64 premarket at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44720209/apple-faces-up-to-90-cost-surge-on-iphones-if-us-tariffs-stick-analyst-looks-at-possible-shift-to-india-price-increase" target="_blank" rel="noreferrer noopener">Apple Faces Up To 90% Cost Surge On iPhones If U.S. Tariffs Stick: Analyst Looks At Possible Shift To India, Price Increase</a></li>
</ul>
Image via Shutterstock

Asia

Earnings

Emerging Markets

Tech

Media

Taiwan Semiconductor Clocks Massive Q1 Revenue Growth Despite US Tensions

B of A Securities analyst Tim Anderson maintains Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Neutral and lowers the price target from $171 to $159.

Price Target

Analyst Ratings

B of A Securities Maintains Neutral on Johnson & Johnson, Lowers Price Target to $159

Macro Notification

General

USA Initial Jobless Claims 223K Vs 223K Est.; 219K Prior

Bitcoin is back below $80,000, currently trading near $78,000 as of Monday. The move follows a steady decline that began Sunday afternoon just ahead of the U.S. futures market open. The Sunday candle topped out at $83,800 before sellers stepped in, continuing the broader trend of weakness that has been developing since late January.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
Bitcoin closed the Sunday bar day down 6%, marking a significant daily loss and highlighting the growing pressure across risk assets. While the selloff has gained momentum, Bitcoin is still trading above a key higher time frame level — the swing low formed on March 11, which bottomed out at $76,560. That level remains a major area of interest for buyers in the short term.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="538" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09105940/IMG_6885-1024x538.png" alt="" class="wp-image-864116" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09105940/IMG_6885-1024x538.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09105940/IMG_6885-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09105940/IMG_6885-768x404.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09105940/IMG_6885-1536x807.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09105940/IMG_6885.png 1600w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Source: TradingView (User &#8211; NoticeTrades) &#8211; Screenshot by @NoticeTrades&nbsp;
After forming a macro high in late January, the market has struggled to regain bullish momentum. Price action has consistently printed lower highs and lost major levels, including the $94,000 to $91,000 support zone. Although that area was retested, Bitcoin failed to reclaim it and continued trending lower.
One of the primary catalysts for this latest leg down appears to be the escalating tariff war between the U.S. and China. Now, with talk of tariffs expanding to other countries, market participants are growing increasingly concerned. Taiwan's announcement of zero tariffs has only added to the uncertainty, raising questions about whether this will pressure other nations to follow suit and what that could mean for global trade.
Trending: <a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a>
At the same time, there are growing fears that the U.S. economy is slowing down faster than expected. JPMorgan Chase recently revised its U.S. real GDP outlook, now projecting a -0.3% contraction for the year, a steep drop from the earlier +1.3% growth estimate. Alongside that, unemployment is expected to rise to 5.3% as economic activity weakens, while core PCE inflation has been revised up to 4.4%, a jump of 1.4 percentage points, largely attributed to the effects of new tariffs.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="456" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110007/IMG_6886-1024x456.jpeg" alt="" class="wp-image-864118" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110007/IMG_6886-1024x456.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110007/IMG_6886-300x134.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110007/IMG_6886-768x342.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110007/IMG_6886.jpeg 1402w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Source: Michael Feroli JP Morgan Newsletter &#8211; Screenshot by @DeItaone on X
With no clear policy roadmap and continued mixed messaging from officials, investor sentiment has taken a serious hit. Some fear gauges are now indicating levels of anxiety even higher than during the 2020 COVID crash, underscoring just how on edge the market has become.
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="816" height="674" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110022/IMG_6887.jpeg" alt="" class="wp-image-864119" style="width:770px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110022/IMG_6887.jpeg 816w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110022/IMG_6887-300x248.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09110022/IMG_6887-768x634.jpeg 768w" sizes="(max-width: 816px) 100vw, 816px" /></figure>
Source: Baker, Bloom, and Davis &#8211; Screenshot by kylascan on X
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Ending Thoughts
Whether $78,000 becomes a short-term bottom or gives way to a deeper pullback will largely depend on how the macro narrative evolves and whether buyers are willing to defend critical support zones.
The important aspect to understand is that this recent downfall isn't just a Bitcoin problem — it's a global economic issue. Risk assets across the board are under pressure, from equities to commodities. Even traditionally "safe" assets like gold have seen a pullback during futures open.
Despite the selloff, Bitcoin is actually holding up relatively well compared to other markets. It's still trading above the election low that I mentioned in a <a href="https://www.benzinga.com/personal-finance/25/04/44626208/crypto-market-update-as-wall-street-sells-off-is-bitcoin-showing-strength-for-the-weeks-ahead">previous article</a>. I expect this relative strength to continue, even if we see further downside across broader markets. I wouldn't be surprised to see Bitcoin rally in the near future if it can maintain its bullish divergence with the stock market.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

Personal Finance

Panic Or Opportunity? Bitcoin Drops To $78K As Fear Takes Over

USA Core CPI (MoM) For March 0.1% Vs 0.3% Est.; 0.2% Prior

CPI (YoY) (Mar) +2.4% vs +2.5% Est.

B of A Securities analyst Tazeen Ahmad maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $63 to $68.

RYTM

B of A Securities Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $68

WIIM

PINS

Pinterest shares are trading lower after Piper Sandler cut its price target on the stock from $41 to $34.

B of A Securities analyst Brad Sills maintains Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) with a Neutral and raises the price target from $22 to $26.

NCNO

B of A Securities Maintains Neutral on Ncino, Raises Price Target to $26

Ford Motor shares are trading lower after Goldman Sachs downgraded the stock from Buy to Neutral and cut its price target from $11 to $9.

JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) will release its first-quarter financial results before the <a href="https://www.benzinga.com/quote/JPM/earnings">opening bell on Friday, April 11</a>.
Analysts expect the bank to report quarterly earnings at $4.64 per share, up from $4.44 per share in the year-ago period. JPMorgan projects quarterly revenue of $44.14 billion, compared to $41.93 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
JPMorgan Chase CEO Jamie Dimon warned on Wednesday that escalating U.S.-China trade tensions have significantly increased the risk of a recession after President Donald Trump&#8217;s tariff policies destabilized financial markets.
With the recent buzz around JPMorgan, some investors may be eyeing potential gains from the company's dividends, too. As of now, JPMorgan offers an annual dividend yield of 2.66%, which is a quarterly dividend amount of $1.40 per share ($5.60 a year).
To figure out how to earn $500 monthly from JPMorgan, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by JPMorgan's $5.60 dividend: $6,000 / $5.60 = 1,071 shares.
So, an investor would need to own approximately $250,978 worth of JPMorgan, or 1,071 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $5.60 = 214 shares, or $50,149 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
JPM Price Action: Shares of JPMorgan gained by 8.1% to close at $234.34 on Wednesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Markets

Trading Ideas

How To Earn $500 A Month From JPMorgan Stock Ahead Of Q1 Earnings

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced today that it has initiated its Phase I/IIa clinical trial at its first U.S. clinical site, the Johns Hopkins University School of Medicine. The first in human clinical trial will investigate the safety, tolerability and full pharmacokinetic profile of Clearmind's innovative treatment, CMND-100, in Alcohol Use Disorder (AUD) patients. This study is the first clinical application of the Company's proprietary CMND-100 platform and marks a significant milestone in the Company's mission to provide innovative solutions for addictions, weight loss and mental health disorders such as depression and anxiety.
The Phase I/IIa trial is designed to assess the safety, tolerability, and pharmacokinetics of CMND-100 in individuals diagnosed with AUD. The study will also include preliminary efficacy evaluations, examining the drug's potential to reduce alcohol cravings and consumption.
CMND-100 is Clearmind's proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel approach by modulating reward mechanisms associated with addictive behavior.
&nbsp;

CMND

Clearmind Medicine Initiates Phase I/IIa Clinical Trial At Its First U.S. Clinical Site, Johns Hopkins University School Of Medicine

Correction: Scotiabank analyst George Farmer downgrades Tempest Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPST#NASDAQ">TPST</a>) from Sector Outperform to Sector Perform and raises the price target from $7 to $9. (Previous Target changed)

Downgrades

Tempest Therapeutics, Inc. - Common Stock

TPST

Correction : Scotiabank Downgrades Tempest Therapeutics to Sector Perform, Raises Price Target to $9 (Previous Target changed)

Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>), a provider of digital marketing software for performance-driven advertisers and agencies, today announced that its Board of Directors has approved a Plan of Dissolution and Liquidation (the "Plan of Dissolution"), subject to the approval of Marin Software's stockholders.
Following a thorough review of strategic alternatives, the Board has determined that an orderly wind-down of Marin Software's operations is in the best interest of stockholders.
If the Plan of Dissolution is approved by stockholders, Marin intends:
<ul>
<li>to wind down and cease its remaining operations in an orderly manner;</li>
<li>to delist its shares of common stock from Nasdaq;</li>
<li>to satisfy or resolve its outstanding liabilities and obligations;</li>
<li>to explore any further opportunities to dispose of some or all of its assets; and</li>
<li>to distribute any available net proceeds to stockholders.</li>
</ul>
Christopher Lien, Founder and Chief Executive Officer of Marin Software, said: "On behalf of Marin Software, I want to thank our customers, partners, team members, and stockholders for their support over the years."
Marin Software expects to convene a special meeting of stockholders during the second quarter of 2025 to seek approval of the Plan of Dissolution, and will file proxy materials with the U.S. Securities and Exchange Commission (SEC) in the coming weeks. Subject to obtaining stockholder approval, Marin Software will begin the dissolution process in accordance with Delaware law.

MRIN

Marin Software Announces That Its Board of Directors Has Approved A Plan of Dissolution And Liquidation , Subject To Approval Of Marin Software's Stockholders

RDDT

Reddit shares are trading lower after Piper Sandler cut its price target on the stock from $220 to $140.

Arthur Hayes, co-founder of BitMEX and one of <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44679289/arthur-hayes-predicts-70-bitcoin-dominance-and-potential-chinese-capital-flight-it-worked-in-2013-2015-and-can-work-in-2025">crypto's most influential voices</a>, has become a case study in how deep macro knowledge and on-chain strategy can lead to massive wealth in volatile markets.
What Happened: In a recent thread, on-chain analyst DeFiTracer <a href="https://x.com/DeFiTracer/status/1909990873590349851">traced</a> Hayes' journey from getting fired in 2013 from an ETF trading desk to becoming a billionaire by pioneering 100x leveraged crypto trading. 
After surviving the Mt. Gox collapse, Hayes co-founded BitMEX with British mathematician Ben Delo, launching the first crypto derivatives exchange of its kind.
Despite legal troubles in 2019 that led to charges related to BitMEX operations, Hayes was later pardoned by President Trump and now enjoys financial freedom having amassed a half-billion-dollar crypto fortune.
The Market Wizard
Hayes not only rode the waves of crypto&#8217;s rise, but he's consistently called major macro moves. He predicted the recent Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dump to $76,000 and even warned about tariff escalations before they happened.
Now, Hayes is accumulating Bitcoin again. 
He believes Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) is the most contrarian bet right now due to market apathy, while Solana's recent surge was meme-fueled and unsustainable.
He also dismissed the idea of governments buying Bitcoin anytime soon, arguing that deficit-heavy nations simply can't justify it when they're under pressure to fund social programs.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44697841/raoul-pal-says-crypto-market-nowhere-near-covid-19-peak-fear">Raoul Pal Says Crypto Market Nowhere Near COVID-19 &#8216;Peak Fear&#8217;</a>
Why It Matters: Hayes believes we're entering an era of fiscal dominance, where money printing becomes the only solution for central banks. In that environment, Bitcoin and fold decouple from traditional assets and become major beneficiaries of global liquidity expansion.
And as he gradually adds to his Bitcoin stack, he's betting that the next rally will be fuelled by central banks — not retail hype.
In a <a href="https://x.com/CryptoHayes/status/1909427649157775851">post</a> on April 8, Hayes floated the idea that if the Federal Reserve doesn&#8217;t spark the next Bitcoin rally, China's central bank might. 
A sharp yuan devaluation, he argues, could trigger another wave of capital flight into crypto — just like it did in 2013 and 2015. That narrative, he says, shouldn't be underestimated heading into 2025.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44698033/millionaire-crypto-trader-reacts-to-bitcoin-mega-crash-you-have-only-one-job-here-survive">Millionaire Crypto Trader Reacts To Bitcoin Mega-Crash: &#8216;You Have Only One Job Here: Survive&#8217;</a></li>
</ul>
Image: Shutterstock

$ETH

How Arthur Hayes Turned $0 Into $500 Million In 6 Years And Predicted Bitcoin's Dump To $76,000

<a href="https://www.wsj.com/business/deals/prada-deal-for-versace-at-risk-of-collapsing-with-market-in-turmoil-93a285fc" title="https://www.wsj.com/business/deals/prada-deal-for-versace-at-risk-of-collapsing-with-market-in-turmoil-93a285fc">https://www.wsj.com/business/deals/prada-deal-for-versace-at-risk-of-collapsing-with-market-in-turmoil-93a285fc</a>

Contracts

CPRI

'Prada Deal For Versace At Risk Of Collapsing With Market In Turmoil; Pending Deal Talks Offer Latest Example Of Trump Trade War Wreaking Havoc On Markets' - WSJ

Snap shares are trading lower after Piper Sandler cut its price target on the stock from $13 to $10.

General Motors shares are trading lower after UBS downgraded the stock from Buy to Neutral and cut its price target from $64 to $51 while Mizuho cut its price target from $63 to $55.

Fidelity Ethereum Fund Beneficial Interest